+++ #NEWS +++ We are pleased to announce topline results from a Phase III trial in men with metastatic hormone-sensitive #ProstateCancer (mHSPC). Learn more: https://lnkd.in/ekY-krjA #TeamBayer #OncologyInspired
I extend my congratulations to #TeamBayer for the tremendous work on today’s exciting news. The unmet medical need in prostate cancer is significant, and today’s news is a vital step forward in our commitment to deliver for prostate cancer patients.
A big congrats to #TeamBayer for your unwavering commitment to serve men impacted by prostate cancer.
Incredible achievement! It's inspiring to see such promising results from the Phase III trial for mHSPC. This breakthrough could bring new hope to many. Kudos to everyone involved for their commitment to making a difference! 🌟 #ProstateCancer
Moving forward!
Congratulations to #TeamBayer and sincere thanks to the patients who participated in this clinical trial and to their families!
Fantastic news! Looking forward to hearing more about the Phase III trial results. Congratulations to #TeamBayer on this achievement in oncology!
Excellent news for patients.
Great news!
Member of the Executive Committee of Bayer AG`s Pharmaceuticals Division and Head, Global Product Strategy and Commercialization
1moEvery patient’s experience of prostate cancer is unique, so it’s critical that patients have options and physicians can tailor treatment plans based on individual patient´s needs. A huge thank you to the multitude of teams for their relentless efforts to achieve this milestone.